These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 349581)

  • 1. The coronary drug project aspirin study. Implications for clinical care. Coronary Drug Project Research Group.
    Prim Care; 1978 Mar; 5(1):91-5. PubMed ID: 349581
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin in coronary heart disease. The Coronary Drug Project Research Group.
    Circulation; 1980 Dec; 62(6 Pt 2):V59-62. PubMed ID: 7002353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin in coronary heart disease. The Coronary Drug Project Research Group.
    J Chronic Dis; 1976 Oct; 29(10):625-42. PubMed ID: 789390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin in coronary heart disease. Comparison of six clinical trials.
    Canner PL
    Isr J Med Sci; 1983 May; 19(5):413-23. PubMed ID: 6345461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Persantin and aspirin in coronary heart disease. The persantin-aspirin reinfarction study group (PARIS)].
    MMW Munch Med Wochenschr; 1980 Dec; 122(49):1761-71. PubMed ID: 6779148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials of platelet-active drugs in coronary heart disease: summary of design features.
    Furberg CD; May GS
    Circulation; 1980 Dec; 62(6 Pt 2):V49-52. PubMed ID: 7002352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials and ischaemic heart disease: can drugs reduce coronary mortality?
    Silke B; Nelson GI; Taylor SH
    Ir Med J; 1982 Aug; 75(8):297-303. PubMed ID: 6127330
    [No Abstract]   [Full Text] [Related]  

  • 8. The Persantine-aspirin reinfarction study. The Persantine-aspirin Reinfarction Study (PARIS) research group.
    Circulation; 1980 Dec; 62(6 Pt 2):V85-8. PubMed ID: 7002354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of ticlopidine monotherapy versus ticlopidine and aspirin after coronary artery stenting: follow-up results of a randomized study.
    Machraoui A; Germing A; Lindstaedt M; von Dryander S; Bojara W; Lawo T; Lemke B; Jaeger D; Grewe P; Deneke T; Barmeyer J
    J Invasive Cardiol; 2001 Jun; 13(6):431-6. PubMed ID: 11385163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Coronary Drug Project: methods and lessons of a multicenter clinical trial. Coronary Drug Project Research Group.
    Control Clin Trials; 1983 Dec; 4(4):1-541. PubMed ID: 6675885
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical assessment of practolol in coronary heart disease.
    Sznajderman M; Wasowska-Ciszek T; Jarecki M; Januszewicz W
    Acta Med Pol; 1973; 14(1):27-33. PubMed ID: 4144420
    [No Abstract]   [Full Text] [Related]  

  • 12. Persantine-aspirin reinfarction study. Design, methods and baseline results. By the persantine-aspirin reinfarction study research group.
    Circulation; 1980 Sep; 62(3 Pt 2):II1-42. PubMed ID: 7408140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Summary of ongoing clinical trials of platelet-active drugs in cardiovascular disease.
    Passamani ER
    Circulation; 1980 Dec; 62(6 Pt 2):V106-10. PubMed ID: 7002348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
    Polli EE; Cortellaro M
    Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of ambulatory follow-up of patients after myocardial infarction treated with platelet aggregation inhibitors and antithrombotic drugs].
    Markiewicz M; Rymar B; Florkiewicz H; Wysokiński A
    Pol Tyg Lek; 1983 Nov; 38(48):1501-3. PubMed ID: 6382203
    [No Abstract]   [Full Text] [Related]  

  • 16. The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group.
    Breddin K; Loew D; Lechner K; Oberla K; Walter E
    Circulation; 1980 Dec; 62(6 Pt 2):V63-72. PubMed ID: 6777073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical studies on application of Visken in treatment of coronary disease (author's transl)].
    Ziólkowski L; Ilmurzyńska K
    Przegl Lek; 1973; 30(9):771-5. PubMed ID: 4587262
    [No Abstract]   [Full Text] [Related]  

  • 18. [Primary prevention of coronary heart disease with aspirin].
    Kübler W
    Z Kardiol; 2004; 93 Suppl 2():II33-6. PubMed ID: 15021994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of findings in the coronary drug project for secondary prevention trials in coronary heart disease. The coronary; drug project research group.
    Canner PL; Halperin M
    Circulation; 1981 Jun; 63(6):1342-50. PubMed ID: 7014029
    [No Abstract]   [Full Text] [Related]  

  • 20. Short-term triple therapy with aspirin, warfarin, and a thienopyridine among patients undergoing percutaneous coronary intervention.
    Porter A; Konstantino Y; Iakobishvili Z; Shachar L; Battler A; Hasdai D
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):56-61. PubMed ID: 16763985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.